| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 132 | 2018 | 784 | 13.090 |
Why?
|
| Nephrectomy | 78 | 2021 | 297 | 12.060 |
Why?
|
| Prostatectomy | 59 | 2016 | 480 | 6.960 |
Why?
|
| Kidney Neoplasms | 51 | 2021 | 557 | 6.860 |
Why?
|
| Robotics | 55 | 2018 | 273 | 6.570 |
Why?
|
| Kidney | 40 | 2021 | 1134 | 4.220 |
Why?
|
| Prostatic Neoplasms | 46 | 2016 | 1798 | 2.960 |
Why?
|
| Warm Ischemia | 13 | 2014 | 33 | 2.290 |
Why?
|
| Urologic Surgical Procedures | 15 | 2018 | 152 | 1.880 |
Why?
|
| Carcinoma, Renal Cell | 16 | 2016 | 366 | 1.790 |
Why?
|
| Middle Aged | 129 | 2021 | 28208 | 1.400 |
Why?
|
| Ureter | 18 | 2017 | 95 | 1.360 |
Why?
|
| Male | 158 | 2021 | 45686 | 1.330 |
Why?
|
| Urologic Neoplasms | 7 | 2017 | 78 | 1.320 |
Why?
|
| Kidney Diseases | 10 | 2012 | 322 | 1.270 |
Why?
|
| Erectile Dysfunction | 8 | 2010 | 79 | 1.270 |
Why?
|
| Ureteral Obstruction | 12 | 2011 | 70 | 1.240 |
Why?
|
| Postoperative Hemorrhage | 4 | 2021 | 50 | 1.150 |
Why?
|
| Treatment Outcome | 66 | 2017 | 9167 | 1.120 |
Why?
|
| Aged | 91 | 2021 | 20848 | 1.120 |
Why?
|
| Suture Techniques | 8 | 2010 | 143 | 1.120 |
Why?
|
| Postoperative Complications | 31 | 2017 | 2592 | 1.120 |
Why?
|
| Humans | 199 | 2021 | 95800 | 1.070 |
Why?
|
| Minimally Invasive Surgical Procedures | 10 | 2014 | 287 | 1.060 |
Why?
|
| Robotic Surgical Procedures | 7 | 2018 | 367 | 1.010 |
Why?
|
| Prostate | 10 | 2011 | 423 | 1.010 |
Why?
|
| Urinary Diversion | 5 | 2017 | 44 | 0.990 |
Why?
|
| Follow-Up Studies | 35 | 2021 | 3904 | 0.960 |
Why?
|
| Adrenalectomy | 3 | 2018 | 45 | 0.950 |
Why?
|
| Lymph Node Excision | 7 | 2017 | 234 | 0.930 |
Why?
|
| Female | 110 | 2021 | 49872 | 0.900 |
Why?
|
| Kidney Pelvis | 12 | 2011 | 52 | 0.890 |
Why?
|
| Intraoperative Complications | 9 | 2018 | 197 | 0.880 |
Why?
|
| Kidney Transplantation | 11 | 2008 | 882 | 0.870 |
Why?
|
| Hypothermia, Induced | 4 | 2010 | 91 | 0.850 |
Why?
|
| Angiomyolipoma | 3 | 2017 | 17 | 0.850 |
Why?
|
| Carcinoma, Transitional Cell | 7 | 2017 | 156 | 0.850 |
Why?
|
| Renal Artery | 4 | 2008 | 46 | 0.840 |
Why?
|
| Creatinine | 9 | 2009 | 299 | 0.810 |
Why?
|
| Swine | 24 | 2013 | 598 | 0.810 |
Why?
|
| Retrospective Studies | 51 | 2017 | 10273 | 0.800 |
Why?
|
| Cystectomy | 5 | 2017 | 114 | 0.780 |
Why?
|
| Embolization, Therapeutic | 2 | 2021 | 279 | 0.770 |
Why?
|
| Glomerular Filtration Rate | 11 | 2021 | 281 | 0.760 |
Why?
|
| Adult | 81 | 2016 | 28578 | 0.740 |
Why?
|
| Urinary Bladder | 10 | 2013 | 263 | 0.730 |
Why?
|
| Ice | 4 | 2010 | 11 | 0.720 |
Why?
|
| Kidney Function Tests | 9 | 2013 | 116 | 0.720 |
Why?
|
| Prospective Studies | 27 | 2017 | 4664 | 0.710 |
Why?
|
| Renal Insufficiency | 2 | 2021 | 99 | 0.700 |
Why?
|
| Preoperative Care | 9 | 2013 | 417 | 0.700 |
Why?
|
| Neoplasm Staging | 23 | 2016 | 2042 | 0.680 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2018 | 85 | 0.680 |
Why?
|
| Laparoscopes | 5 | 2008 | 15 | 0.670 |
Why?
|
| Obesity | 5 | 2018 | 1030 | 0.660 |
Why?
|
| Time Factors | 23 | 2021 | 5561 | 0.650 |
Why?
|
| Kidney Tubules, Collecting | 3 | 2009 | 25 | 0.650 |
Why?
|
| Body Mass Index | 4 | 2014 | 815 | 0.620 |
Why?
|
| Seminal Vesicles | 6 | 2012 | 39 | 0.590 |
Why?
|
| Renal Veins | 3 | 2008 | 27 | 0.590 |
Why?
|
| Surgical Instruments | 4 | 2007 | 63 | 0.580 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 5 | 2008 | 143 | 0.580 |
Why?
|
| Sutures | 4 | 2009 | 59 | 0.580 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2016 | 1463 | 0.580 |
Why?
|
| Urology | 6 | 2008 | 133 | 0.560 |
Why?
|
| Urinary Incontinence | 6 | 2012 | 217 | 0.550 |
Why?
|
| Ureteroscopy | 11 | 2007 | 38 | 0.550 |
Why?
|
| Sus scrofa | 6 | 2013 | 48 | 0.540 |
Why?
|
| Nephrostomy, Percutaneous | 6 | 1998 | 30 | 0.530 |
Why?
|
| Adenocarcinoma | 5 | 2009 | 1192 | 0.530 |
Why?
|
| Reperfusion Injury | 2 | 2010 | 148 | 0.530 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2009 | 2773 | 0.510 |
Why?
|
| Urinary Bladder, Neurogenic | 3 | 2011 | 30 | 0.510 |
Why?
|
| Electrocoagulation | 2 | 2008 | 22 | 0.500 |
Why?
|
| Aged, 80 and over | 32 | 2016 | 7215 | 0.500 |
Why?
|
| Catheter Ablation | 3 | 2008 | 266 | 0.490 |
Why?
|
| Urination Disorders | 5 | 2008 | 56 | 0.480 |
Why?
|
| Multivariate Analysis | 15 | 2017 | 1008 | 0.480 |
Why?
|
| Ureteral Neoplasms | 3 | 2006 | 13 | 0.450 |
Why?
|
| General Surgery | 2 | 2008 | 255 | 0.440 |
Why?
|
| Logistic Models | 10 | 2021 | 1267 | 0.430 |
Why?
|
| Diagnostic Errors | 2 | 2013 | 158 | 0.430 |
Why?
|
| Anastomosis, Surgical | 7 | 2011 | 284 | 0.420 |
Why?
|
| Prognosis | 11 | 2017 | 3990 | 0.390 |
Why?
|
| Quality Improvement | 1 | 2017 | 502 | 0.390 |
Why?
|
| Retroperitoneal Neoplasms | 2 | 2006 | 42 | 0.380 |
Why?
|
| Models, Animal | 5 | 2010 | 286 | 0.370 |
Why?
|
| Risk Factors | 15 | 2021 | 5961 | 0.360 |
Why?
|
| Lithotripsy | 6 | 2003 | 45 | 0.350 |
Why?
|
| Sural Nerve | 2 | 2008 | 18 | 0.350 |
Why?
|
| Pneumoperitoneum, Artificial | 3 | 2007 | 7 | 0.330 |
Why?
|
| Ileum | 4 | 2010 | 169 | 0.330 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 258 | 0.330 |
Why?
|
| Animals | 37 | 2013 | 28889 | 0.330 |
Why?
|
| Ultrasonic Therapy | 2 | 2008 | 43 | 0.330 |
Why?
|
| Living Donors | 6 | 2007 | 348 | 0.330 |
Why?
|
| Retroperitoneal Fibrosis | 2 | 2007 | 6 | 0.330 |
Why?
|
| Hemostatics | 2 | 2008 | 61 | 0.320 |
Why?
|
| Postoperative Period | 6 | 2018 | 318 | 0.320 |
Why?
|
| Materials Testing | 2 | 2007 | 94 | 0.320 |
Why?
|
| Carcinoma | 1 | 2013 | 444 | 0.320 |
Why?
|
| Age Factors | 7 | 2014 | 1957 | 0.310 |
Why?
|
| Recovery of Function | 3 | 2010 | 348 | 0.310 |
Why?
|
| Prostate-Specific Antigen | 7 | 2013 | 346 | 0.310 |
Why?
|
| Risk Assessment | 11 | 2017 | 2480 | 0.300 |
Why?
|
| Postoperative Care | 7 | 2014 | 238 | 0.300 |
Why?
|
| Proportional Hazards Models | 6 | 2021 | 900 | 0.300 |
Why?
|
| Overweight | 2 | 2008 | 121 | 0.290 |
Why?
|
| Reoperation | 4 | 2009 | 707 | 0.280 |
Why?
|
| Analysis of Variance | 5 | 2014 | 908 | 0.280 |
Why?
|
| Hemostasis, Surgical | 1 | 2008 | 25 | 0.280 |
Why?
|
| Ultrasonography, Interventional | 1 | 2008 | 125 | 0.280 |
Why?
|
| Adrenocortical Adenoma | 1 | 2007 | 2 | 0.280 |
Why?
|
| Occupational Diseases | 2 | 2008 | 55 | 0.270 |
Why?
|
| Disease Models, Animal | 8 | 2012 | 2534 | 0.270 |
Why?
|
| Neuromuscular Diseases | 1 | 2008 | 29 | 0.270 |
Why?
|
| Waxes | 1 | 2007 | 1 | 0.270 |
Why?
|
| Palmitates | 1 | 2007 | 17 | 0.270 |
Why?
|
| Fellowships and Scholarships | 2 | 2007 | 145 | 0.270 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2007 | 21 | 0.270 |
Why?
|
| Arthritis | 1 | 2008 | 53 | 0.270 |
Why?
|
| Biopsy | 9 | 2016 | 1208 | 0.270 |
Why?
|
| Kidney Calculi | 6 | 2000 | 345 | 0.270 |
Why?
|
| Medical Illustration | 2 | 2007 | 17 | 0.270 |
Why?
|
| Pneumothorax | 1 | 2007 | 52 | 0.260 |
Why?
|
| Intestines | 1 | 2010 | 432 | 0.260 |
Why?
|
| Stents | 9 | 2007 | 422 | 0.260 |
Why?
|
| Aneurysm, False | 1 | 2007 | 55 | 0.260 |
Why?
|
| Polycystic Kidney Diseases | 2 | 2004 | 22 | 0.260 |
Why?
|
| Ischemic Preconditioning | 1 | 2007 | 37 | 0.260 |
Why?
|
| Intraoperative Period | 4 | 2008 | 98 | 0.250 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 212 | 0.250 |
Why?
|
| Tensile Strength | 1 | 2007 | 86 | 0.250 |
Why?
|
| Papilloma, Inverted | 1 | 2006 | 6 | 0.250 |
Why?
|
| Feasibility Studies | 7 | 2010 | 816 | 0.250 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2006 | 11 | 0.240 |
Why?
|
| Cushing Syndrome | 1 | 2006 | 25 | 0.240 |
Why?
|
| Surveys and Questionnaires | 10 | 2010 | 2859 | 0.240 |
Why?
|
| Liposarcoma | 1 | 2006 | 10 | 0.240 |
Why?
|
| Equipment Design | 8 | 2012 | 427 | 0.240 |
Why?
|
| Retroperitoneal Space | 1 | 2006 | 42 | 0.240 |
Why?
|
| Tumor Burden | 3 | 2017 | 322 | 0.230 |
Why?
|
| Predictive Value of Tests | 10 | 2016 | 1805 | 0.230 |
Why?
|
| Learning | 2 | 2015 | 305 | 0.230 |
Why?
|
| Biopsy, Needle | 7 | 2013 | 231 | 0.230 |
Why?
|
| Demography | 4 | 2010 | 189 | 0.230 |
Why?
|
| Urography | 13 | 2009 | 41 | 0.230 |
Why?
|
| Blood Specimen Collection | 1 | 2005 | 28 | 0.220 |
Why?
|
| Cystoscopy | 3 | 2008 | 37 | 0.220 |
Why?
|
| Diagnosis, Differential | 6 | 2011 | 1615 | 0.220 |
Why?
|
| Kidney Calices | 3 | 1999 | 5 | 0.220 |
Why?
|
| Catheterization | 3 | 2005 | 237 | 0.220 |
Why?
|
| Surgical Stapling | 1 | 2004 | 17 | 0.220 |
Why?
|
| Tissue Donors | 2 | 2008 | 542 | 0.220 |
Why?
|
| Argon | 1 | 2004 | 10 | 0.220 |
Why?
|
| Regression Analysis | 3 | 2013 | 599 | 0.220 |
Why?
|
| Sensitivity and Specificity | 5 | 2008 | 2039 | 0.220 |
Why?
|
| Nomograms | 3 | 2009 | 35 | 0.210 |
Why?
|
| Catheters, Indwelling | 1 | 2005 | 113 | 0.210 |
Why?
|
| Swine, Miniature | 11 | 2003 | 56 | 0.210 |
Why?
|
| Physicians | 2 | 2009 | 706 | 0.200 |
Why?
|
| Adipose Tissue | 1 | 2006 | 271 | 0.200 |
Why?
|
| Cystostomy | 3 | 2011 | 15 | 0.200 |
Why?
|
| Probability | 5 | 2010 | 364 | 0.190 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 564 | 0.190 |
Why?
|
| Case-Control Studies | 3 | 2021 | 1957 | 0.190 |
Why?
|
| Laser Therapy | 2 | 2012 | 151 | 0.190 |
Why?
|
| Blood Loss, Surgical | 4 | 2008 | 133 | 0.190 |
Why?
|
| Cold Ischemia | 2 | 2014 | 22 | 0.190 |
Why?
|
| Urinary Calculi | 2 | 1999 | 46 | 0.190 |
Why?
|
| Neoplasms, Second Primary | 1 | 2004 | 245 | 0.180 |
Why?
|
| Cohort Studies | 8 | 2013 | 3106 | 0.170 |
Why?
|
| Iatrogenic Disease | 1 | 2021 | 72 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 7 | 2016 | 579 | 0.170 |
Why?
|
| Endoscopy, Digestive System | 1 | 2001 | 72 | 0.170 |
Why?
|
| Endoscopy | 4 | 1998 | 374 | 0.160 |
Why?
|
| Appendix | 2 | 2011 | 31 | 0.160 |
Why?
|
| Neoplasm Grading | 4 | 2016 | 404 | 0.160 |
Why?
|
| Urinary Reservoirs, Continent | 3 | 2011 | 14 | 0.160 |
Why?
|
| Hyperaldosteronism | 1 | 2000 | 13 | 0.160 |
Why?
|
| Patient Positioning | 2 | 2018 | 65 | 0.160 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2000 | 28 | 0.160 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 1079 | 0.160 |
Why?
|
| Anuria | 1 | 1999 | 6 | 0.150 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 995 | 0.150 |
Why?
|
| Disease-Free Survival | 5 | 2016 | 1194 | 0.150 |
Why?
|
| Organ Size | 4 | 2010 | 376 | 0.150 |
Why?
|
| Education, Medical, Graduate | 2 | 2009 | 436 | 0.150 |
Why?
|
| Margins of Excision | 2 | 2017 | 45 | 0.150 |
Why?
|
| Constriction | 2 | 2009 | 27 | 0.150 |
Why?
|
| Absorbable Implants | 1 | 1999 | 37 | 0.150 |
Why?
|
| Random Allocation | 3 | 2008 | 321 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 1425 | 0.140 |
Why?
|
| Diverticulum | 1 | 1998 | 45 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 3 | 2010 | 432 | 0.140 |
Why?
|
| Urologic Diseases | 2 | 2017 | 42 | 0.140 |
Why?
|
| Preoperative Period | 1 | 2018 | 98 | 0.140 |
Why?
|
| Adenoma | 1 | 2000 | 260 | 0.140 |
Why?
|
| Pheochromocytoma | 1 | 2018 | 52 | 0.140 |
Why?
|
| Nephroureterectomy | 1 | 2017 | 1 | 0.130 |
Why?
|
| Extracellular Matrix | 1 | 1999 | 255 | 0.130 |
Why?
|
| Drainage | 2 | 2014 | 172 | 0.130 |
Why?
|
| Intraoperative Care | 2 | 2010 | 89 | 0.130 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2008 | 517 | 0.130 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2008 | 382 | 0.130 |
Why?
|
| Health Plan Implementation | 1 | 2017 | 65 | 0.130 |
Why?
|
| Ureteral Calculi | 2 | 2010 | 10 | 0.130 |
Why?
|
| Child | 6 | 2017 | 7618 | 0.130 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 128 | 0.130 |
Why?
|
| Radiography, Abdominal | 2 | 2007 | 67 | 0.130 |
Why?
|
| Rhabdomyolysis | 2 | 2015 | 28 | 0.120 |
Why?
|
| Perioperative Care | 4 | 2016 | 188 | 0.120 |
Why?
|
| Polyglactin 910 | 2 | 2007 | 5 | 0.120 |
Why?
|
| Survival Analysis | 3 | 2017 | 1540 | 0.120 |
Why?
|
| Incidence | 5 | 2013 | 1714 | 0.120 |
Why?
|
| Survival Rate | 5 | 2015 | 1971 | 0.120 |
Why?
|
| Operative Time | 2 | 2013 | 167 | 0.120 |
Why?
|
| Pelvis | 3 | 2015 | 103 | 0.120 |
Why?
|
| Cadaver | 2 | 2008 | 204 | 0.120 |
Why?
|
| Lymphatic Metastasis | 4 | 2015 | 506 | 0.120 |
Why?
|
| Reference Values | 2 | 2007 | 674 | 0.120 |
Why?
|
| Rectal Diseases | 1 | 2015 | 23 | 0.120 |
Why?
|
| Cornea | 1 | 1996 | 55 | 0.120 |
Why?
|
| Intestinal Perforation | 1 | 2015 | 39 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2010 | 3639 | 0.110 |
Why?
|
| Young Adult | 7 | 2016 | 7026 | 0.110 |
Why?
|
| Acute Disease | 2 | 2007 | 859 | 0.110 |
Why?
|
| Aspirin | 1 | 2016 | 169 | 0.110 |
Why?
|
| Neoplasm, Residual | 3 | 2012 | 196 | 0.110 |
Why?
|
| Equipment Failure | 3 | 2015 | 128 | 0.110 |
Why?
|
| In Vitro Techniques | 3 | 2010 | 1008 | 0.110 |
Why?
|
| Blood Vessels | 2 | 2015 | 92 | 0.110 |
Why?
|
| Models, Biological | 2 | 2012 | 1809 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 180 | 0.110 |
Why?
|
| Urinary Catheters | 1 | 2014 | 6 | 0.100 |
Why?
|
| Adolescent | 7 | 2016 | 9873 | 0.100 |
Why?
|
| Ablation Techniques | 2 | 2011 | 41 | 0.100 |
Why?
|
| Nephrons | 2 | 2012 | 17 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 883 | 0.100 |
Why?
|
| Peritoneal Diseases | 1 | 2013 | 15 | 0.100 |
Why?
|
| Urodynamics | 4 | 2008 | 130 | 0.100 |
Why?
|
| Length of Stay | 4 | 2013 | 833 | 0.100 |
Why?
|
| Neoplasm Seeding | 4 | 2008 | 16 | 0.100 |
Why?
|
| Urinary Catheterization | 1 | 2014 | 40 | 0.100 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2013 | 15 | 0.100 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 1827 | 0.100 |
Why?
|
| Critical Pathways | 1 | 2013 | 36 | 0.100 |
Why?
|
| Linear Models | 2 | 2014 | 438 | 0.100 |
Why?
|
| Lasers, Gas | 1 | 2012 | 4 | 0.100 |
Why?
|
| Ureterostomy | 2 | 2006 | 3 | 0.100 |
Why?
|
| Likelihood Functions | 1 | 2013 | 257 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2013 | 109 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2000 | 1201 | 0.090 |
Why?
|
| Device Removal | 1 | 2014 | 166 | 0.090 |
Why?
|
| Clinical Competence | 4 | 2009 | 854 | 0.090 |
Why?
|
| Quality of Life | 4 | 2008 | 1816 | 0.090 |
Why?
|
| Risk | 2 | 2010 | 665 | 0.090 |
Why?
|
| Kidney Diseases, Cystic | 2 | 2004 | 22 | 0.090 |
Why?
|
| Mathematics | 2 | 2010 | 191 | 0.090 |
Why?
|
| Testicular Neoplasms | 1 | 2013 | 122 | 0.090 |
Why?
|
| Ostomy | 1 | 2011 | 15 | 0.090 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2009 | 118 | 0.080 |
Why?
|
| Radiography | 5 | 2006 | 823 | 0.080 |
Why?
|
| Comorbidity | 1 | 2014 | 1011 | 0.080 |
Why?
|
| Frozen Sections | 1 | 2010 | 50 | 0.080 |
Why?
|
| Hypertension, Renal | 2 | 2008 | 19 | 0.080 |
Why?
|
| Spinal Dysraphism | 1 | 2010 | 29 | 0.080 |
Why?
|
| Suspensions | 1 | 2010 | 6 | 0.080 |
Why?
|
| Patient Discharge | 1 | 2013 | 361 | 0.080 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2010 | 23 | 0.080 |
Why?
|
| Hospitals, University | 4 | 2003 | 199 | 0.080 |
Why?
|
| Urine | 2 | 2002 | 96 | 0.080 |
Why?
|
| Particle Size | 1 | 2010 | 126 | 0.080 |
Why?
|
| Life Expectancy | 1 | 2010 | 91 | 0.080 |
Why?
|
| Body Temperature | 1 | 2010 | 131 | 0.080 |
Why?
|
| Weight Loss | 1 | 2011 | 240 | 0.080 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2009 | 239 | 0.080 |
Why?
|
| Credentialing | 1 | 2009 | 14 | 0.080 |
Why?
|
| Lymphocele | 1 | 2009 | 6 | 0.080 |
Why?
|
| Wolffian Ducts | 1 | 2009 | 8 | 0.080 |
Why?
|
| Prostatic Hyperplasia | 1 | 2010 | 97 | 0.070 |
Why?
|
| Ossification, Heterotopic | 1 | 2009 | 32 | 0.070 |
Why?
|
| Therapeutic Irrigation | 2 | 2010 | 66 | 0.070 |
Why?
|
| Femoral Artery | 1 | 2009 | 91 | 0.070 |
Why?
|
| Databases as Topic | 1 | 2009 | 96 | 0.070 |
Why?
|
| Equipment Safety | 1 | 2008 | 32 | 0.070 |
Why?
|
| Ligation | 2 | 2009 | 53 | 0.070 |
Why?
|
| Drug Combinations | 2 | 2007 | 213 | 0.070 |
Why?
|
| Fasciotomy | 2 | 2009 | 19 | 0.070 |
Why?
|
| Posture | 2 | 1999 | 130 | 0.070 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2009 | 78 | 0.070 |
Why?
|
| Lymph Nodes | 2 | 2010 | 554 | 0.070 |
Why?
|
| Incidental Findings | 2 | 2009 | 99 | 0.070 |
Why?
|
| Peripheral Nerve Injuries | 2 | 2015 | 19 | 0.070 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2008 | 16 | 0.070 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2009 | 121 | 0.070 |
Why?
|
| Aorta | 1 | 2009 | 294 | 0.070 |
Why?
|
| Remission, Spontaneous | 1 | 2007 | 45 | 0.070 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2008 | 26 | 0.070 |
Why?
|
| Punctures | 1 | 2007 | 29 | 0.070 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2008 | 76 | 0.070 |
Why?
|
| Intestine, Small | 2 | 2000 | 310 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2010 | 983 | 0.070 |
Why?
|
| Hypertension | 3 | 2003 | 774 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2008 | 192 | 0.070 |
Why?
|
| Polypropylenes | 1 | 2007 | 23 | 0.060 |
Why?
|
| Radioisotope Renography | 1 | 2007 | 6 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2008 | 327 | 0.060 |
Why?
|
| Nephrology | 1 | 2007 | 46 | 0.060 |
Why?
|
| Cryosurgery | 2 | 2004 | 65 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2007 | 182 | 0.060 |
Why?
|
| Vascular Surgical Procedures | 1 | 2008 | 152 | 0.060 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2008 | 98 | 0.060 |
Why?
|
| Glucocorticoids | 2 | 2007 | 369 | 0.060 |
Why?
|
| Intestinal Mucosa | 2 | 2002 | 825 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2011 | 3970 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2007 | 295 | 0.060 |
Why?
|
| Transplantation, Autologous | 2 | 2004 | 361 | 0.060 |
Why?
|
| Hospitals | 1 | 2008 | 329 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2007 | 333 | 0.060 |
Why?
|
| Traction | 1 | 2005 | 8 | 0.060 |
Why?
|
| Surgical Staplers | 1 | 2004 | 10 | 0.060 |
Why?
|
| Jugular Veins | 1 | 2005 | 73 | 0.050 |
Why?
|
| Equipment and Supplies | 1 | 2004 | 32 | 0.050 |
Why?
|
| Thromboembolism | 1 | 2005 | 128 | 0.050 |
Why?
|
| Arteriovenous Fistula | 1 | 2004 | 54 | 0.050 |
Why?
|
| Urology Department, Hospital | 1 | 2003 | 1 | 0.050 |
Why?
|
| Androgens | 1 | 2004 | 177 | 0.050 |
Why?
|
| ROC Curve | 3 | 2012 | 797 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2006 | 936 | 0.050 |
Why?
|
| Urinary Tract Infections | 2 | 2001 | 85 | 0.050 |
Why?
|
| Disease Progression | 1 | 2008 | 1559 | 0.050 |
Why?
|
| Lymphoma, B-Cell | 1 | 2004 | 111 | 0.050 |
Why?
|
| Pain | 2 | 2003 | 426 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2004 | 175 | 0.050 |
Why?
|
| Renal Circulation | 1 | 2003 | 37 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2004 | 263 | 0.050 |
Why?
|
| Lithotripsy, Laser | 2 | 1999 | 3 | 0.050 |
Why?
|
| Tomography, Spiral Computed | 1 | 2002 | 77 | 0.050 |
Why?
|
| Ohio | 1 | 2002 | 42 | 0.050 |
Why?
|
| Hemostasis | 1 | 2002 | 24 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2004 | 252 | 0.050 |
Why?
|
| Models, Anatomic | 1 | 2002 | 93 | 0.040 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2002 | 83 | 0.040 |
Why?
|
| Computer-Assisted Instruction | 1 | 2002 | 48 | 0.040 |
Why?
|
| Genital Diseases, Male | 1 | 2001 | 9 | 0.040 |
Why?
|
| Hematuria | 2 | 2000 | 50 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2017 | 713 | 0.040 |
Why?
|
| Hydronephrosis | 1 | 2001 | 30 | 0.040 |
Why?
|
| Ultrasonography | 5 | 2004 | 747 | 0.040 |
Why?
|
| Education, Medical, Continuing | 3 | 2009 | 111 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2002 | 196 | 0.040 |
Why?
|
| Ureteroscopes | 1 | 2000 | 3 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2013 | 220 | 0.040 |
Why?
|
| Cysts | 1 | 2001 | 104 | 0.040 |
Why?
|
| Biocompatible Materials | 2 | 1999 | 201 | 0.040 |
Why?
|
| Sepsis | 1 | 2005 | 389 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2000 | 71 | 0.040 |
Why?
|
| Replantation | 1 | 2000 | 36 | 0.040 |
Why?
|
| Pyelonephritis, Xanthogranulomatous | 1 | 1999 | 3 | 0.040 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2000 | 111 | 0.040 |
Why?
|
| Dilatation | 1 | 1999 | 48 | 0.040 |
Why?
|
| Silicones | 1 | 1999 | 21 | 0.040 |
Why?
|
| Algorithms | 1 | 2007 | 2015 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 1670 | 0.040 |
Why?
|
| Urothelium | 1 | 1999 | 69 | 0.040 |
Why?
|
| Tuberculosis, Renal | 1 | 1998 | 1 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2004 | 1126 | 0.040 |
Why?
|
| Urinary Bladder Diseases | 1 | 1998 | 42 | 0.030 |
Why?
|
| Digestive System Surgical Procedures | 1 | 1999 | 134 | 0.030 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 1998 | 26 | 0.030 |
Why?
|
| Treatment Failure | 1 | 1998 | 297 | 0.030 |
Why?
|
| Curriculum | 1 | 2002 | 615 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 1998 | 132 | 0.030 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1998 | 150 | 0.030 |
Why?
|
| Models, Statistical | 2 | 2012 | 594 | 0.030 |
Why?
|
| Health Care Rationing | 1 | 2017 | 85 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1996 | 26 | 0.030 |
Why?
|
| Radio Waves | 1 | 1996 | 20 | 0.030 |
Why?
|
| Anesthesia | 2 | 2009 | 175 | 0.030 |
Why?
|
| Immersion | 1 | 1996 | 22 | 0.030 |
Why?
|
| Corneal Injuries | 1 | 1996 | 8 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1998 | 208 | 0.030 |
Why?
|
| Denervation | 2 | 2008 | 25 | 0.030 |
Why?
|
| Hyperthermia, Induced | 1 | 1996 | 75 | 0.030 |
Why?
|
| Phentolamine | 1 | 1995 | 8 | 0.030 |
Why?
|
| Papaverine | 1 | 1995 | 5 | 0.030 |
Why?
|
| Alprostadil | 1 | 1995 | 26 | 0.030 |
Why?
|
| Incisional Hernia | 1 | 2015 | 19 | 0.030 |
Why?
|
| Pain, Postoperative | 2 | 2014 | 277 | 0.030 |
Why?
|
| Cattle | 1 | 1996 | 385 | 0.030 |
Why?
|
| Morbidity | 1 | 2015 | 160 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2016 | 180 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 1319 | 0.030 |
Why?
|
| Internship and Residency | 2 | 2017 | 1134 | 0.030 |
Why?
|
| Water | 1 | 1996 | 307 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2013 | 647 | 0.030 |
Why?
|
| Patient Selection | 2 | 2013 | 708 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 2013 | 53 | 0.030 |
Why?
|
| Indiana | 2 | 2003 | 13 | 0.020 |
Why?
|
| Pliability | 1 | 2012 | 5 | 0.020 |
Why?
|
| Pregnancy | 1 | 2000 | 3237 | 0.020 |
Why?
|
| Infant | 1 | 1999 | 3360 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 1010 | 0.020 |
Why?
|
| Rats | 2 | 2009 | 4154 | 0.020 |
Why?
|
| Chicago | 1 | 2016 | 1505 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1127 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 60 | 0.020 |
Why?
|
| Atherectomy | 1 | 2010 | 4 | 0.020 |
Why?
|
| Radionuclide Imaging | 2 | 2003 | 206 | 0.020 |
Why?
|
| United States | 2 | 2015 | 7764 | 0.020 |
Why?
|
| Cause of Death | 1 | 2011 | 278 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 124 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 186 | 0.020 |
Why?
|
| Aortography | 1 | 2009 | 67 | 0.020 |
Why?
|
| Vas Deferens | 1 | 2009 | 8 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 108 | 0.020 |
Why?
|
| Rats, Mutant Strains | 1 | 2008 | 23 | 0.020 |
Why?
|
| Wound Healing | 2 | 2002 | 378 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2010 | 298 | 0.020 |
Why?
|
| Retreatment | 2 | 1998 | 106 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2008 | 340 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2008 | 84 | 0.020 |
Why?
|
| Delayed Graft Function | 1 | 2007 | 16 | 0.020 |
Why?
|
| Heterozygote | 1 | 2008 | 382 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 365 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 362 | 0.020 |
Why?
|
| Rabbits | 2 | 1998 | 639 | 0.020 |
Why?
|
| Palpation | 1 | 2005 | 19 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2007 | 294 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 777 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 1211 | 0.010 |
Why?
|
| Missouri | 1 | 2003 | 19 | 0.010 |
Why?
|
| Ischemia | 1 | 2006 | 256 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2004 | 315 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2004 | 238 | 0.010 |
Why?
|
| Renal Plasma Flow | 1 | 2003 | 1 | 0.010 |
Why?
|
| p-Aminohippuric Acid | 1 | 2003 | 4 | 0.010 |
Why?
|
| Graft Survival | 1 | 2007 | 942 | 0.010 |
Why?
|
| Inulin | 1 | 2003 | 17 | 0.010 |
Why?
|
| Awards and Prizes | 1 | 2003 | 37 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2003 | 119 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 2003 | 99 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2003 | 173 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 2003 | 122 | 0.010 |
Why?
|
| Analgesics | 1 | 2003 | 132 | 0.010 |
Why?
|
| Emergencies | 1 | 2002 | 123 | 0.010 |
Why?
|
| Models, Structural | 1 | 2000 | 58 | 0.010 |
Why?
|
| Biodegradation, Environmental | 1 | 2000 | 18 | 0.010 |
Why?
|
| Lighting | 1 | 2000 | 34 | 0.010 |
Why?
|
| Shoulder Pain | 1 | 2000 | 7 | 0.010 |
Why?
|
| Back Injuries | 1 | 2000 | 6 | 0.010 |
Why?
|
| Sprains and Strains | 1 | 2000 | 12 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2000 | 267 | 0.010 |
Why?
|
| Abdominal Muscles | 1 | 2000 | 23 | 0.010 |
Why?
|
| Pressure | 1 | 2000 | 175 | 0.010 |
Why?
|
| Neuralgia | 1 | 2000 | 33 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 1739 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2000 | 162 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2002 | 483 | 0.010 |
Why?
|
| Decision Trees | 1 | 1999 | 63 | 0.010 |
Why?
|
| Health Surveys | 1 | 2000 | 245 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1999 | 68 | 0.010 |
Why?
|
| Fiber Optic Technology | 1 | 1999 | 36 | 0.010 |
Why?
|
| Decision Making | 1 | 2004 | 694 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2003 | 775 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 1999 | 179 | 0.010 |
Why?
|
| Artificial Organs | 1 | 1998 | 4 | 0.010 |
Why?
|
| Triamcinolone | 1 | 1998 | 20 | 0.010 |
Why?
|
| Antitubercular Agents | 1 | 1998 | 61 | 0.010 |
Why?
|
| Dissection | 1 | 1998 | 45 | 0.010 |
Why?
|
| Omentum | 1 | 1998 | 68 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2003 | 766 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 1981 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2002 | 1878 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2000 | 364 | 0.010 |
Why?
|
| Remission Induction | 1 | 1998 | 750 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1998 | 787 | 0.010 |
Why?
|
| Necrosis | 1 | 1996 | 210 | 0.010 |
Why?
|
| Impotence, Vasculogenic | 1 | 1995 | 3 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1996 | 411 | 0.010 |
Why?
|
| Penile Erection | 1 | 1995 | 22 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 1998 | 259 | 0.010 |
Why?
|
| Injections | 1 | 1995 | 126 | 0.010 |
Why?
|
| Penis | 1 | 1995 | 65 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1995 | 1791 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 2386 | 0.010 |
Why?
|